ERIS LIFESCIENCES LIMITED

{
    "company_profile": "Eris Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the manufacture and marketing of pharmaceutical products. The Company has a presence in major therapies like oral anti-diabetes, insulins, cardiovascular, vitamins/minerals and dermatology. Its flagship therapies include oral anti-diabetes, cardiovascular disease (CVD), and vitamins, minerals and nutrients (VMN). Its emerging therapies consist of dermatology, insulins, women\u2019s health, central nervous system (CNS), oncology, and nephrology. Its portfolio of brands includes Glimisave, Eritel, LNBloc, Olmin, Crevast, Atorsave, Gluxit, Renerve, Zomelis, Cosvate, Tayo, Cyblex, Remylin, Tendia, Rabonik, Ginkocer, Psorid, Raricap, Serlift, and Onabet, among others. Its patient care initiatives (PCI) platform provides various healthcare solutions to its patients. The Company has a manufacturing plant located in Guwahati, Assam.",
    "sector": "Pharmaceuticals",
    "sector_market_cap_inr": {
        "value": 15911.93,
        "unit": "crore",
        "formatted": "15,911.93 Cr"
    },
    "sector_market_cap_usd": {
        "value": 1.77,
        "unit": "billion",
        "formatted": "$1.77B"
    }
}